Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
US ˙ NasdaqCM ˙ US00653A1079

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for M James Barrett. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at M James Barrett har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:SENS / Senseonics Holdings, Inc. Director 86.930
US:PHAS / PhaseBio Pharmaceuticals Inc 10% Owner 0
US:CLVS / Clovis Oncology Inc Director 14.770
US:ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) 10% Owner 82.978.668
10% Owner 40.702
US:BE / Bloom Energy Corporation 10% Owner 7.729.641
Director, 10% Owner 15.300
US:ARDX / Ardelyx, Inc. 10% Owner 9.169.210
US:GLYC / GlycoMimetics, Inc. Director, 10% Owner 11.000
US:MULE / Mulesoft, Inc. 10% Owner 0
US:SURF / Surface Oncology Inc 10% Owner 0
US:TCON / TRACON Pharmaceuticals, Inc. 10% Owner 707.964
US:TSRO / TESARO, Inc. 10% Owner 9.681.129
US:TNTR / Tintri, Inc. 10% Owner 0
US:RARX / Ra Pharmaceuticals, Inc. 10% Owner 5.490.073
US:APPN / Appian Corporation 10% Owner 0
US:SYBX / Synlogic, Inc. 10% Owner 4.228.940
US:SBBP / Strongbridge Biopharma plc 10% Owner 8.282.616
US:CRCM / Care.com, Inc. 10% Owner 252
US:RYTM / Rhythm Pharmaceuticals, Inc. 10% Owner 0
US:MRSN / Mersana Therapeutics, Inc. 10% Owner 0
US:ROKA / Roka Bioscience, Inc. Director, 10% Owner 3.000
US:ZSAN / Zosano Pharma Corp 10% Owner 952.809
US:ILIU / Interleukin Genetics, Inc. 10% Owner 20.120.724
US:OPWR / Opower, Inc. 10% Owner 0
US:SUPN / Supernus Pharmaceuticals, Inc. Director 97.355
US:TRIV / TriVascular Technologies, Inc. 10% Owner 0
US:EPZM / Epizyme Inc 10% Owner 5.854.351
US:AVTX / Avalo Therapeutics, Inc. 10% Owner 0
US:LOXO / Loxo Oncology, Inc. Director, 10% Owner 7.812
US:VTAE / Vitae Pharmaceuticals, Inc. 10% Owner 464
US:HPTX / Hyperion Therapeutics Inc 10% Owner 0
US:CSBR / Champions Oncology, Inc. 10% Owner 37.500.000
US:BOX / Box, Inc. 10% Owner 2.091.457
US:US09739CAB81 / Boingo Wireless Bond 10% Owner 3.569.210
US:TRVN / Trevena, Inc. 10% Owner 4.811.691
US:DATA / Tableau Software, Inc. 10% Owner 1.964.192
US:CVT / Cvent Holding Corp 10% Owner 2.639
US:DERM / Journey Medical Corporation 10% Owner 0
10% Owner 4.659.333
US:FOLD / Amicus Therapeutics, Inc. Director, 10% Owner 15.000
10% Owner 0
US:ECOM / ChannelAdvisor Corp 10% Owner 0
US:TRGT / Targacept 10% Owner 0
US:ADNC / Audience Inc 10% Owner 0
10% Owner 952
US:GRPN / Groupon, Inc. 10% Owner 41.260
Director, 10% Owner 0
US:WDAY / Workday, Inc. 10% Owner 4.642.425
US:MM / 10% Owner 8.196.614
US:FIO / Franklin Income Opportunities Fund 10% Owner 1.333
10% Owner 15.000
US:ECHO / Echo Global Logistics Inc 10% Owner 0
US:INHX / Inhibitex, Inc. Director, 10% Owner 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af M James Barrett. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) Insider Trades
Insidersalg ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) Insider Trades
Insiderkøb APPN / Appian Corporation – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

APPN / Appian Corporation Insider Trades
Insidersalg APPN / Appian Corporation – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

APPN / Appian Corporation Insider Trades
Insiderkøb ARDX / Ardelyx, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-06-24 ARDX New Enterprise Associates 12, Limited Partnership 510.442 14,0000 510.442 14,0000 7.146.188 162 32.89 9.642.249 134,93

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ARDX / Ardelyx, Inc. Insider Trades
Insidersalg ARDX / Ardelyx, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2014-12-26 ARDX BARRETT M JAMES 296 21,5449 296 21,5449 6.377 131 8.32 -3.914 -61,38
2014-12-26 ARDX BARRETT M JAMES 296 21,5449 296 21,5449 6.377
2014-12-26 ARDX BARRETT M JAMES 1.972 21,2784 1.972 21,2784 41.961

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ARDX / Ardelyx, Inc. Insider Trades
Insiderkøb AVTX / Avalo Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AVTX / Avalo Therapeutics, Inc. Insider Trades
Insidersalg AVTX / Avalo Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AVTX / Avalo Therapeutics, Inc. Insider Trades
Insiderkøb BE / Bloom Energy Corporation – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2018-07-27 BE NEW ENTERPRISE ASSOCIATES 10 L P 1.333.333 15,0000 1.333.333 15,0000 19.999.995 61 35.8 27.733.326 138,67

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BE / Bloom Energy Corporation Insider Trades
Insidersalg BE / Bloom Energy Corporation – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BE / Bloom Energy Corporation Insider Trades
Insiderkøb BOX / Box, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BOX / Box, Inc. Insider Trades
Insidersalg BOX / Box, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BOX / Box, Inc. Insider Trades
Insiderkøb CSBR / Champions Oncology, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CSBR / Champions Oncology, Inc. Insider Trades
Insidersalg CSBR / Champions Oncology, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CSBR / Champions Oncology, Inc. Insider Trades
Insiderkøb DERM / Journey Medical Corporation – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

DERM / Journey Medical Corporation Insider Trades
Insidersalg DERM / Journey Medical Corporation – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

DERM / Journey Medical Corporation Insider Trades
Insiderkøb FOLD / Amicus Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FOLD / Amicus Therapeutics, Inc. Insider Trades
Insidersalg FOLD / Amicus Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FOLD / Amicus Therapeutics, Inc. Insider Trades
Insiderkøb GRPN / Groupon, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GRPN / Groupon, Inc. Insider Trades
Insidersalg GRPN / Groupon, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2013-08-15 GRPN BARRETT M JAMES 3.846 9,7700 192 195,4000 37.575 265 5.3300 -36.552 -97,28
2013-08-15 GRPN BARRETT M JAMES 27.595 9,7709 1.380 195,4180 269.628

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GRPN / Groupon, Inc. Insider Trades
Insiderkøb MRSN / Mersana Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MRSN / Mersana Therapeutics, Inc. Insider Trades
Insidersalg MRSN / Mersana Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MRSN / Mersana Therapeutics, Inc. Insider Trades
Insiderkøb RYTM / Rhythm Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RYTM / Rhythm Pharmaceuticals, Inc. Insider Trades
Insidersalg RYTM / Rhythm Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RYTM / Rhythm Pharmaceuticals, Inc. Insider Trades
Insiderkøb SENS / Senseonics Holdings, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SENS / Senseonics Holdings, Inc. Insider Trades
Insidersalg SENS / Senseonics Holdings, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SENS / Senseonics Holdings, Inc. Insider Trades
Insiderkøb SUPN / Supernus Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SUPN / Supernus Pharmaceuticals, Inc. Insider Trades
Insidersalg SUPN / Supernus Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2015-12-08 SUPN BARRETT M JAMES 70.913 14,7498 70.913 14,7498 1.045.953 58 10.1300 -327.603 -31,32
2015-12-07 SUPN BARRETT M JAMES 71.067 14,3835 71.067 14,3835 1.022.192
2015-12-04 SUPN BARRETT M JAMES 70.990 14,5394 70.990 14,5394 1.032.152
2015-11-25 SUPN BARRETT M JAMES 16.179 16,3480 16.179 16,3480 264.494
2015-11-18 SUPN BARRETT M JAMES 43.000 16,5010 43.000 16,5010 709.543
2015-11-17 SUPN BARRETT M JAMES 50.000 16,7092 50.000 16,7092 835.460
2015-11-16 SUPN BARRETT M JAMES 19.650 16,1341 19.650 16,1341 317.035
2015-11-13 SUPN BARRETT M JAMES 100.000 16,2561 100.000 16,2561 1.625.610
2015-06-16 SUPN BARRETT M JAMES 55.105 16,8527 55.105 16,8527 928.668

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SUPN / Supernus Pharmaceuticals, Inc. Insider Trades
Insiderkøb SYBX / Synlogic, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SYBX / Synlogic, Inc. Insider Trades
Insidersalg SYBX / Synlogic, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SYBX / Synlogic, Inc. Insider Trades
Insiderkøb TRVN / Trevena, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2014-12-10 TRVN New Enterprise Associates 12, Limited Partnership 1.000.000 4,0000 40.000 100,0000 4.000.000 282 332.5 9.300.000 232,50
2014-02-05 TRVN New Enterprise Associates 12, Limited Partnership 472.410 7,0000 18.896 175,0000 3.306.870

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TRVN / Trevena, Inc. Insider Trades
Insidersalg TRVN / Trevena, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TRVN / Trevena, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af M James Barrett som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2019-06-03 2019-05-30 4 SENS Senseonics Holdings, Inc.
Stock Option (right to buy)
A - Award 86.930 86.930
2019-01-04 2019-01-02 4 SENS Senseonics Holdings, Inc.
Common Stock
A - Award 3.624 512.720 0,71 2,69 9.749 1.379.217
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
C - Conversion -1.124.301 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
C - Conversion -437.706 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
S - Sale -4.349 437.706 -0,98 5,00 -21.745 2.188.530
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
X - Other 181.190 442.055 69,46 0,12 21.743 53.047
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
X - Other -181.190 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
C - Conversion -3.279.627 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
S - Sale -1.177 3.279.627 -0,04 5,00 -5.885 16.398.135
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
X - Other 49.030 3.280.804 1,52 0,12 5.884 393.696
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series B Preferred Stock
X - Other -49.030 0 -100,00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 1.800.000 6.641.634 37,18 5,00 9.000.000 33.208.170
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
C - Conversion 4.841.634 4.841.634
2018-10-15 2018-10-11 4 CLVS Clovis Oncology, Inc.
Stock Option (Right to Buy)
A - Award 14.770 14.770
2018-10-03 2018-10-01 4 SENS Senseonics Holdings, Inc.
Common Stock
A - Award 2.147 509.096 0,42 4,54 9.747 2.311.296
2018-09-10 2018-09-07 4 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share
P - Purchase 3.000.000 82.978.668 3,75 1,67 5.000.100 138.300.546
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Warrant to purchase Common Stock
J - Other 40.702 40.702
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Warrant to purchase Series D Preferred Stock
J - Other -684.911 0 -100,00
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Series D Preferred Stock
C - Conversion -16.502.833 0 -100,00
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Series C Preferred Stock
C - Conversion -3.337.206 0 -100,00
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Series B Preferred Stock
C - Conversion -3.645.307 0 -100,00
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Common Stock
P - Purchase 545.455 2.484.870 28,12 11,00 6.000.005 27.333.570
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Common Stock
C - Conversion 980.715 1.939.415 102,30
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Common Stock
C - Conversion 432.033 958.700 82,03
2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Common Stock
C - Conversion 515.547 526.667 4.636,21
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class B Common Stock
C - Conversion 346.239 7.729.641 4,69
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
8% Convertible Preferred Notes
C - Conversion -346.239 0 -100,00
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class B Common Stock
C - Conversion 650.631 7.383.402 9,66
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Series G Convertible Preferred Stock
C - Conversion -650.631 0 -100,00
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class B Common Stock
C - Conversion 125.989 6.732.771 1,91
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Series F Convertible Preferred Stock
C - Conversion -125.989 0 -100,00
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class B Common Stock
C - Conversion 395.815 6.606.782 6,37
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Series E Convertible Preferred Stock
C - Conversion -395.815 0 -100,00
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class B Common Stock
C - Conversion 620.155 6.210.967 11,09
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Series D Convertible Preferred Stock
C - Conversion -620.155 0 -100,00
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class B Common Stock
C - Conversion 1.062.944 5.590.812 23,48
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Series C Convertible Preferred Stock
C - Conversion -1.062.944 0 -100,00
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class B Common Stock
C - Conversion 4.527.868 4.527.868
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Series B Convertible Preferred Stock
C - Conversion -4.527.868 0 -100,00
2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class A Common Stock
P - Purchase 1.333.333 1.333.333 15,00 19.999.995 19.999.995
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22.240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22.240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22.240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22.240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22.240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22.240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22.240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22.240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22.240
2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock
22.240
2018-07-05 2018-07-02 4 SENS Senseonics Holdings, Inc.
Common Stock
A - Award 2.200 506.949 0,44 4,43 9.746 2.245.784
2018-06-19 2018-06-15 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Stock Option (Right to Buy)
A - Award 15.300 15.300
2018-06-01 2018-05-30 4 SENS Senseonics Holdings, Inc.
Stock Option (right to buy)
A - Award 50.847 50.847
2018-05-30 2018-05-25 4 ARDX ARDELYX, INC.
Common Stock
A - Award 416.667 9.169.210 4,76 4,00 1.666.668 36.676.840
2018-05-21 2018-05-18 4 GLYC GLYCOMIMETICS INC
Stock Option (right to buy)
A - Award 11.000 11.000
2018-05-11 2018-05-10 4 GLYC GLYCOMIMETICS INC
Warrant to Purchase Common Stock (right to buy)
X - Other -298.406 0 -100,00
2018-05-11 2018-05-10 4 GLYC GLYCOMIMETICS INC
Warrant to Purchase Common Stock (right to buy)
X - Other -216.046 0 -100,00
2018-05-11 2018-05-10 4 GLYC GLYCOMIMETICS INC
Common Stock
S - Sale -5.533 4.995.664 -0,11 17,81 -98.543 88.972.776
2018-05-11 2018-05-10 4 GLYC GLYCOMIMETICS INC
Common Stock
X - Other 298.406 5.001.197 6,35 0,33 98.474 1.650.395
2018-05-11 2018-05-10 4 GLYC GLYCOMIMETICS INC
Common Stock
S - Sale -4.006 4.702.791 -0,09 17,81 -71.347 83.756.708
2018-05-11 2018-05-10 4 GLYC GLYCOMIMETICS INC
Common Stock
X - Other 216.046 4.706.797 4,81 0,33 71.295 1.553.243
2018-05-09 2018-05-01 4 MULE MULESOFT, INC
Class B Common Stock
C - Conversion -12.679.970 0 -100,00
2018-05-09 2018-05-01 4 MULE MULESOFT, INC
Class A Common Stock
U - Other -12.679.970 0 -100,00
2018-05-09 2018-05-01 4 MULE MULESOFT, INC
Class A Common Stock
C - Conversion 12.679.970 12.679.970
2018-04-23 2018-04-23 4 SURF Surface Oncology, Inc.
Series A Preferred Stock
C - Conversion -6.995.000 0 -100,00
2018-04-23 2018-04-23 4 SURF Surface Oncology, Inc.
Common Stock
P - Purchase 133.333 3.312.877 4,19 15,00 1.999.995 49.693.155
2018-04-23 2018-04-23 4 SURF Surface Oncology, Inc.
Common Stock
C - Conversion 3.179.544 3.179.544
2018-04-09 2018-04-02 4 SENS Senseonics Holdings, Inc.
Common Stock
A - Award 3.145 504.749 0,63 3,10 9.750 1.564.722
2018-03-28 2018-03-27 4 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share
P - Purchase 6.000.000 79.978.672 8,11 1,92 11.500.200 153.295.121
2018-03-28 2018-03-26 4 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share
P - Purchase 571.164 73.978.672 0,78 1,90 1.087.553 140.862.789
2018-03-27 2018-03-27 4 TCON Tracon Pharmaceuticals, Inc.
Warrant to Purchase Common Stock
P - Purchase 707.964 707.964 0,12 88.496 88.496
2018-03-27 2018-03-27 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
P - Purchase 707.964 3.466.003 25,67 2,70 1.911.503 9.358.208
2018-03-23 2018-03-23 4 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share
P - Purchase 294.090 73.407.508 0,40 1,95 572.358 142.865.692
2018-03-23 2018-03-22 4 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share
P - Purchase 869.574 73.113.418 1,20 1,90 1.655.669 139.207.948
2018-03-23 2018-03-21 4 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share
P - Purchase 104.844 72.243.844 0,15 1,81 189.820 130.797.480
2018-03-06 2018-03-06 4 TSRO TESARO, Inc.
Common Stock
P - Purchase 12.634 9.681.129 0,13 59,82 755.708 579.080.604
2018-03-06 2018-03-05 4 TSRO TESARO, Inc.
Common Stock
P - Purchase 17.248 9.668.495 0,18 59,76 1.030.813 577.829.869
2018-03-06 2018-03-05 4 TSRO TESARO, Inc.
Common Stock
P - Purchase 1.600 9.651.247 0,02 59,15 94.634 570.832.655
2018-03-06 2018-03-05 4 TSRO TESARO, Inc.
Common Stock
P - Purchase 30.321 9.649.647 0,32 58,28 1.767.153 562.395.902
2018-03-06 2018-03-02 4 TSRO TESARO, Inc.
Common Stock
P - Purchase 17.859 9.619.326 0,19 57,34 1.024.114 551.614.478
2018-03-06 2018-03-02 4 TSRO TESARO, Inc.
Common Stock
P - Purchase 4.080 9.601.467 0,04 56,66 231.174 544.022.961
2018-03-06 2018-03-02 4 TSRO TESARO, Inc.
Common Stock
P - Purchase 6.399 9.597.387 0,07 55,01 352.005 527.946.500
2018-03-06 2018-03-02 4 TSRO TESARO, Inc.
Common Stock
P - Purchase 26.304 9.590.988 0,28 54,32 1.428.875 520.997.814
2018-03-02 2018-02-26 4 TNTR Tintri, Inc.
Note Purchase Agreement (obligation to purchase)
E - Other 0
2018-02-21 2018-02-16 4 RARX Ra Pharmaceuticals, Inc.
Common Stock
P - Purchase 2.000.000 5.490.073 57,31 6,00 12.000.000 32.940.438
2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class B Common Stock
C - Conversion -2.724.202 0 -100,00
2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock
J - Other 339 1.015 50,15
2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock
J - Other 339 1.015 50,15
2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock
J - Other 676 676
2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock
J - Other 676 676
2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock
J - Other -13.621 0 -100,00
2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock
J - Other 13.621 13.621
2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock
J - Other -27.242 0 -100,00
2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock
J - Other 27.242 27.242
2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock
J - Other -2.724.202 0 -100,00
2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock
C - Conversion 2.724.202 2.724.202
2018-01-26 2018-01-26 4 SYBX SYNLOGIC, INC.
Common Stock
A - Award 410.000 4.228.940 10,74 9,75 3.997.500 41.232.165
2018-01-09 3 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value
8.282.616
2018-01-09 3 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value
8.282.616
2018-01-04 2018-01-02 4 SENS Senseonics Holdings, Inc.
Common Stock
A - Award 3.665 501.604 0,74 2,66 9.749 1.334.267
2017-12-19 2017-12-18 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock
P - Purchase 2.000.000 5.554.610 56,26 5,00 10.000.000 27.773.050
2017-11-27 2017-11-27 4 APPN APPIAN CORP
Class B Common Stock
C - Conversion -569.620 2.724.202 -17,29
2017-11-27 2017-11-27 4 APPN APPIAN CORP
Class A Common Stock
S - Sale -569.620 0 -100,00 19,49 -11.101.894
2017-11-27 2017-11-27 4 APPN APPIAN CORP
Class A Common Stock
C - Conversion 569.620 569.620
2017-11-21 2017-11-20 4 APPN APPIAN CORP
Class B Common Stock
C - Conversion -2.820.516 3.293.822 -46,13
2017-11-21 2017-11-20 4 APPN APPIAN CORP
Class A Common Stock
S - Sale -2.820.516 0 -100,00 19,49 -54.971.857
2017-11-21 2017-11-20 4 APPN APPIAN CORP
Class A Common Stock
C - Conversion 2.820.516 2.820.516
2017-11-08 2017-11-06 4 CRCM Care.com Inc
Common Stock
J - Other 252 252
2017-11-08 2017-11-06 4 CRCM Care.com Inc
Common Stock
J - Other 252 252
2017-11-08 2017-11-06 4 CRCM Care.com Inc
Common Stock
J - Other -10.000 0 -100,00
2017-11-08 2017-11-06 4 CRCM Care.com Inc
Common Stock
J - Other 10.000 10.000
2017-11-08 2017-11-06 4 CRCM Care.com Inc
Common Stock
J - Other -1.000.000 2.256.013 -30,71
2017-10-16 2017-10-12 4 SENS Senseonics Holdings, Inc.
Common Stock
A - Award 3.250 497.939 0,66
2017-10-10 2017-10-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Series A-1 Junior Preferred Stock
C - Conversion -2.927.708 0 -100,00
2017-10-10 2017-10-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Series A Preferred Stoc
C - Conversion -1.402.870 0 -100,00
2017-10-10 2017-10-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
P - Purchase 550.000 4.909.956 12,61 17,00 9.350.000 83.469.252
2017-10-10 2017-10-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
C - Conversion 2.927.708 4.359.956 204,41
2017-10-10 2017-10-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
C - Conversion 1.402.870 1.432.248 4.775,24
2017-10-04 3 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
58.756
2017-10-04 3 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock
58.756
2017-08-30 2017-08-28 4 SYBX SYNLOGIC, INC.
Common Stock
A - Award 3.394.439 3.818.940 799,63
2017-08-07 2017-08-03 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Stock Option (Right to Buy)
A - Award 63.663 63.663
2017-07-06 2017-07-03 4 MRSN Mersana Therapeutics, Inc.
Series C-1 Preferred Stock
C - Conversion -2.216.626 0 -100,00
2017-07-06 2017-07-03 4 MRSN Mersana Therapeutics, Inc.
Series B-1 Preferred Stock
C - Conversion -18.001.419 0 -100,00
2017-07-06 2017-07-03 4 MRSN Mersana Therapeutics, Inc.
Series A-1 Preferred Stock
C - Conversion -11.931.173 0 -100,00
2017-07-06 2017-07-03 4 MRSN Mersana Therapeutics, Inc.
Common Stock
P - Purchase 1.000.000 8.140.138 14,01 15,00 15.000.000 122.102.070
2017-07-06 2017-07-03 4 MRSN Mersana Therapeutics, Inc.
Common Stock
C - Conversion 7.140.138 7.140.138
2017-06-30 2017-06-28 4 ROKA Roka BioScience, Inc.
Stock Option (right to buy)
A - Award -3.000 3.000 -50,00
2017-06-08 2017-06-08 4 CLVS Clovis Oncology, Inc.
Stock Option (Right to Buy)
A - Award 10.000 10.000
2017-06-05 2017-06-01 4 SENS Senseonics Holdings, Inc.
Common Stock
P - Purchase 7.092.198 21.911.183 47,86 1,41 9.999.999 30.894.768
2017-05-31 2017-05-31 4 APPN APPIAN CORP
Class B Common Stock
C - Conversion 6.114.338 6.114.338
2017-05-31 2017-05-31 4 APPN APPIAN CORP
Series B Convertible Preferred Stock
C - Conversion -6.114.338 0 -100,00
2017-05-30 2017-05-25 4 GLYC GLYCOMIMETICS INC
Stock Option (right to buy)
A - Award 11.000 11.000
2017-05-26 2017-05-24 4 SENS Senseonics Holdings, Inc.
Stock Option (right to buy)
A - Award 128.817 128.817
2017-03-28 2017-03-27 4 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share
P - Purchase 12.870.000 72.139.000 21,71 0,70 9.009.000 50.497.300
2017-03-22 2017-03-22 4 MULE MULESOFT, INC
Class B Common Stock
J - Other 12.679.970 12.679.970
2017-03-22 2017-03-22 4 MULE MULESOFT, INC
Series G Preferred Stock
C - Conversion -605.668 0 -100,00
2017-03-22 2017-03-22 4 MULE MULESOFT, INC
Series F Preferred Stock
C - Conversion -2.064.048 0 -100,00
2017-03-22 2017-03-22 4 MULE MULESOFT, INC
Series E Preferred Stock
C - Conversion -8.000.038 0 -100,00
2017-03-22 2017-03-22 4 MULE MULESOFT, INC
Series A Preferred Stock
C - Conversion -1.689.436 0 -100,00
2017-03-22 2017-03-22 4 MULE MULESOFT, INC
Common Stock
J - Other -12.679.970 0 -100,00
2017-03-22 2017-03-22 4 MULE MULESOFT, INC
Common Stock
C - Conversion 12.359.190 12.679.970 3.852,86
2017-03-16 3 MULE MULESOFT, INC
Common Stock
641.560
2017-03-16 3 MULE MULESOFT, INC
Common Stock
641.560
2017-03-01 2017-02-27 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other 287 861 50,00
2017-03-01 2017-02-27 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other 287 861 50,00
2017-03-01 2017-02-27 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other -11.399 0 -100,00
2017-03-01 2017-02-27 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other 11.399 11.399
2017-03-01 2017-02-27 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other -1.139.890 0 -100,00
2017-02-14 2017-02-13 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -1.099.996 952.809 -53,59 2,01 -2.211.432 1.915.527
2016-11-29 2016-11-29 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
P - Purchase 869.565 2.758.039 46,05 5,75 4.999.999 15.858.724
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Series B-2 Preferred Stock
C - Conversion -4.362.472 0 -100,00
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Series B-1 Preferred Stock
C - Conversion -4.689.657 0 -100,00
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Series A Preferred Stock
C - Conversion -12.447.605 0 -100,00
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Warrants to Purchase Common Stock
X - Other -80.658 0 -100,00
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock
P - Purchase 338.462 3.490.073 10,74 13,00 4.400.006 45.370.949
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock
C - Conversion 623.210 3.151.611 24,65
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock
C - Conversion 669.951 2.528.401 36,05
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock
C - Conversion 1.778.227 1.858.450 2.216,60
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock
S - Sale -435 80.223 -0,54 13,00 -5.655 1.042.899
2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock
X - Other 80.658 80.658 0,07 5.646 5.646
2016-09-30 2016-09-21 4/A ROKA Roka BioScience, Inc.
Series A Convertible Preferred Stock
P - Purchase 4.000 4.000
2016-09-23 2016-09-21 4 ROKA Roka BioScience, Inc.
Warrant to Purchase Common Stock (right to buy)
P - Purchase 5.714.286 5.714.286
2016-09-23 2016-09-21 4 ROKA Roka BioScience, Inc.
Series A Convertible Preferred Stock
P - Purchase 4.000 4.000
2016-09-20 2016-09-16 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -7.471 2.052.805 -0,36 0,75 -5.603 1.539.604
2016-09-15 2016-09-13 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -10.000 2.060.276 -0,48 0,74 -7.400 1.524.604
2016-09-15 2016-09-14 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock
P - Purchase 461.538 3.554.610 14,92 13,00 5.999.994 46.209.930
2016-08-31 2016-08-29 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -50.000 2.070.276 -2,36 1,01 -50.440 2.088.494
2016-08-26 2016-08-24 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -1.200 2.120.276 -0,06 1,21 -1.452 2.565.534
2016-08-02 2016-07-29 4 ILIU INTERLEUKIN GENETICS INC
Common Stock Warrant (right to buy)
P - Purchase 20.120.724 20.120.724
2016-08-02 2016-07-29 4 ILIU INTERLEUKIN GENETICS INC
Common Stock
P - Purchase 20.120.724 55.418.811 57,00 0,10 2.000.000 5.508.630
2016-07-21 2016-07-21 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -8.989 2.121.476 -0,42 1,33 -11.957 2.821.987
2016-07-21 2016-07-20 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -14.158 2.130.465 -0,66 1,24 -17.550 2.640.924
2016-07-21 2016-07-19 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -534 2.144.623 -0,02 1,17 -625 2.509.209
2016-07-20 2016-07-18 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 763.650 8.752.543 9,56 8,73 6.666.664 76.409.700
2016-07-15 2016-07-13 4 ZSAN Zosano Pharma Corp
Common Stock
S - Sale -13.382 2.145.157 -0,62 1,20 -16.060 2.574.403
2016-06-24 2016-06-22 4 ROKA Roka BioScience, Inc.
Stock Option (right to buy)
A - Award -30.000 30.000 -50,00
2016-06-14 2016-06-14 4 OPWR OPOWER, INC.
Common Stock
U - Other -8.989.766 0 -100,00 10,30 -92.594.590
2016-06-13 2016-06-09 4 CLVS Clovis Oncology, Inc.
Stock Option (Right to Buy)
A - Award 10.000 10.000
2016-05-26 2016-05-24 4 SENS Senseonics Holdings, Inc.
Stock Option (right to buy)
A - Award 54.629 54.629
2016-05-19 2016-05-17 4 GLYC GLYCOMIMETICS INC
Stock Option (right to buy)
A - Award 11.000 11.000
2016-03-24 2016-03-16 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
G - Gift -18.000 97.355 -15,60
2016-03-23 2016-03-23 4 SENS Senseonics Holdings, Inc.
Common Stock
P - Purchase 1.578.947 14.818.985 11,93 2,85 4.499.999 42.234.107
2016-03-18 2016-03-18 4 TSRO TESARO, Inc.
Common Stock
P - Purchase 710.429 9.564.684 8,02 35,19 24.999.997 336.581.230
2016-03-17 3 SENS Senseonics Holdings, Inc.
Common Stock
14.381.495
2016-03-17 3 SENS Senseonics Holdings, Inc.
Common Stock
14.038.885
2016-03-17 3 SENS Senseonics Holdings, Inc.
Common Stock
27.126.844
2016-03-17 3 SENS Senseonics Holdings, Inc.
Common Stock
14.381.495
2016-03-17 3 SENS Senseonics Holdings, Inc.
Common Stock
14.038.885
2016-03-17 3 SENS Senseonics Holdings, Inc.
Common Stock
27.126.844
2016-03-03 2016-03-01 4 SUPN SUPERNUS PHARMACEUTICALS INC
Director Stock Option (Right to Buy)
A - Award 15.000 15.000
2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Series B Convertible Redeemable Preferred Stock
C - Conversion -4.423.723 0 -100,00
2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Series A Convertible Preferred Stock
C - Conversion -13.848.000 0 -100,00
2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock
P - Purchase 900.324 3.093.072 41,06 8,00 7.202.592 24.744.576
2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock
C - Conversion 2.192.748 2.192.748
2016-02-12 2016-02-10 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Stock Option (Right to Buy)
A - Award 45.760 45.760
2016-02-04 2016-02-03 4 TRIV TriVascular Technologies, Inc.
Common Stock
D - Sale to Issuer -3.943.269 0 -100,00
2016-01-14 2016-01-13 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 500.000 7.988.893 6,68 10,00 5.000.000 79.888.930
2016-01-12 2016-01-12 4 EPZM Epizyme, Inc.
Common Stock
P - Purchase 1.111.111 5.854.351 23,43 9,00 9.999.999 52.689.159
2016-01-04 3 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share
118.538.000
2016-01-04 3 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share
118.538.000
2015-12-08 2015-12-08 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale -70.913 0 -100,00 14,75 -1.045.953
2015-12-08 2015-12-07 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale -71.067 70.913 -50,05 14,38 -1.022.192 1.019.977
2015-12-08 2015-12-04 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale -70.990 141.980 -33,33 14,54 -1.032.152 2.064.304
2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 212.970 212.970
2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 8.733 24.317 56,04
2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 11.980 33.360 56,03
2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 20.713 57.678 56,03
2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 41.426 115.355 56,03
2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other -1.172.932 0 -100,00
2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 1.172.932 1.172.932
2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other -3.820.625 0 -100,00
2015-11-30 2015-11-25 4 SUPN SUPERNUS PHARMACEUTICALS INC
Director Stock Option (Right to Buy)
M - Exercise -7.457 0 -100,00
2015-11-30 2015-11-25 4 SUPN SUPERNUS PHARMACEUTICALS INC
Director Stock Option (Right to Buy)
M - Exercise -8.722 0 -100,00
2015-11-30 2015-11-25 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale -16.179 73.929 -17,96 16,35 -264.494 1.208.591
2015-11-30 2015-11-25 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise 7.457 90.108 9,02 9,24 68.903 832.598
2015-11-30 2015-11-25 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
M - Exercise 8.722 82.651 11,80 7,90 68.904 652.943
2015-11-18 2015-11-16 4 GLYC GLYCOMIMETICS INC
Warrant to Purchase Common Stock (right to buy)
X - Other -9.445 0 -100,00 0,33 -3.117
2015-11-18 2015-11-16 4 GLYC GLYCOMIMETICS INC
Common Stock
S - Sale -452 4.490.751 -0,01 6,91 -3.123 31.031.089
2015-11-18 2015-11-16 4 GLYC GLYCOMIMETICS INC
Common Stock
X - Other 9.445 4.491.203 0,21 0,33 3.117 1.482.097
2015-11-18 2015-11-18 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale -43.000 0 -100,00 16,50 -709.543
2015-11-18 2015-11-17 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale -50.000 43.000 -53,76 16,71 -835.460 718.496
2015-11-17 2015-11-16 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale -19.650 93.000 -17,44 16,13 -317.035 1.500.471
2015-11-17 2015-11-13 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale -100.000 112.650 -47,03 16,26 -1.625.610 1.831.250
2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 212.650 212.650
2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 8.728 15.584 127,30
2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 11.974 21.380 127,30
2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 20.703 36.965 127,31
2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 41.405 73.929 127,31
2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other -1.172.932 0 -100,00
2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 1.172.932 1.172.932
2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other -3.820.625 3.820.625 -50,00
2015-10-20 2015-10-20 4 CERC Cerecor Inc.
Series B Convertible Preferred Stock
C - Conversion -16.638.880 0 -100,00
2015-10-20 2015-10-20 4 CERC Cerecor Inc.
Common Stock
C - Conversion 594.245 594.245
2015-10-06 2015-10-06 4 MIRN Mirna Therapeutics, Inc.
Common Stock
P - Purchase 857.142 2.971.517 40,54 7,00 5.999.994 20.800.619
2015-10-06 2015-10-06 4 MIRN Mirna Therapeutics, Inc.
Common Stock
J - Other 31.650 2.114.375 1,52
2015-10-06 2015-10-06 4 MIRN Mirna Therapeutics, Inc.
Common Stock
J - Other 257.516 1.499.166 20,74
2015-10-06 2015-10-05 4 MIRN Mirna Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -583.559 0 -100,00
2015-10-06 2015-10-05 4 MIRN Mirna Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -1.241.650 0 -100,00
2015-10-06 2015-10-05 4 MIRN Mirna Therapeutics, Inc.
Common Stock
C - Conversion 583.559 2.082.725 38,93
2015-10-06 2015-10-05 4 MIRN Mirna Therapeutics, Inc.
Common Stock
C - Conversion 1.241.650 1.241.650
2015-08-11 2015-07-15 4 GLYC GLYCOMIMETICS INC
Stock Option (right to buy)
A - Award 11.000 11.000
2015-07-30 2015-07-28 4 LOXO Loxo Oncology, Inc.
Director Stock Option (right to buy)
A - Award 7.812 7.812
2015-07-02 2015-07-01 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
J - Other 464 464
2015-07-02 2015-07-01 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
J - Other 1.134 1.134
2015-07-02 2015-07-01 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
I - Other -8.250 0 -100,00
2015-07-02 2015-07-01 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
J - Other 8.250 8.250
2015-07-02 2015-07-01 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
J - Other -825.000 1.786.564 -31,59
2015-06-26 2015-06-24 4 ROKA Roka BioScience, Inc.
Stock Option (right to buy)
A - Award -15.000 15.000 -50,00
2015-06-19 2015-06-17 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale -48.796 0 -100,00 16,02 -781.800
2015-06-19 2015-06-17 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale -63.085 48.796 -56,39 16,67 -1.051.804 813.566
2015-06-17 2015-06-16 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
S - Sale -55.105 111.881 -33,00 16,85 -928.668 1.885.497
2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 166.986 166.986
2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 6.856 6.856
2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 9.406 9.406
2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 16.262 16.262
2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 32.524 32.524
2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other -921.000 921.000 -50,00
2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other 921.000 921.000
2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
J - Other -3.000.000 7.641.250 -28,19
2015-06-15 2015-06-11 4 CLVS Clovis Oncology, Inc.
Stock Option (Right to Buy)
A - Award 10.000 10.000
2015-06-09 2015-06-05 4 ARDX ARDELYX, INC.
Common Stock Warrant (right to buy)
P - Purchase 560.748 560.748 0,12 70.094 70.094
2015-06-09 2015-06-05 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 1.869.159 7.488.893 33,26 10,70 20.000.001 80.131.155
2015-06-04 2015-06-02 4 TSRO TESARO, Inc.
Common Stock
S - Sale -629 0 -100,00 58,13 -36.564
2015-06-04 2015-06-02 4 TSRO TESARO, Inc.
Common Stock
S - Sale -1.500 629 -70,46 57,55 -86.332 36.202
2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock
J - Other 252 252
2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock
J - Other 252 252
2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock
J - Other 2.129 2.129
2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock
J - Other -10.000 0 -100,00
2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock
J - Other 10.000 10.000
2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock
J - Other -1.000.000 8.854.255 -10,15
2015-05-15 2015-05-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1.924 0 -100,00 92,57 -178.107
2015-05-15 2015-05-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -500 1.924 -20,63 91,86 -45.932 176.746
2015-05-15 2015-05-14 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other 2.424 2.424
2015-05-15 2015-05-14 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other 287 574 100,00
2015-05-15 2015-05-14 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other 287 574 100,00
2015-05-15 2015-05-14 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other -11.399 0 -100,00
2015-05-15 2015-05-14 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other 11.399 11.399
2015-05-15 2015-05-14 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other -1.139.891 1.139.890 -50,00
2015-05-11 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
U - Other -2.384.221 0 -100,00 46,00 -109.674.166
2015-03-24 3 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
37.500.000
2015-03-24 3 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock
37.500.000
2015-03-05 2015-03-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Director Stock Option (Right to Buy)
A - Award 20.000 20.000
2015-02-05 2015-02-04 4 TCON Tracon Pharmaceuticals, Inc.
Series B Redeemable Convertible Preferred Stock
C - Conversion -5.373.396 0 -100,00
2015-02-05 2015-02-04 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
P - Purchase 500.000 1.888.474 36,01 10,00 5.000.000 18.884.740
2015-02-05 2015-02-04 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
C - Conversion 1.388.474 1.388.474
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
8% Convertible Note Issued 9/9/2013
C - Conversion
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
8% Convertible Note Issued 12/2/2014
C - Conversion
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
8% Convertible Note Issued 2/26/2014
C - Conversion
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
Common Stock
P - Purchase 23.457 2.158.539 1,10 11,00 258.027 23.743.929
2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
Common Stock
C - Conversion 341.201 2.135.082 19,02 9,35 3.190.229 19.963.017
2015-01-29 2015-01-28 4 BOX BOX INC
Class B Common Stock
J - Other 2.091.457 2.091.457
2015-01-29 2015-01-28 4 BOX BOX INC
Series E Preferred Stock
C - Conversion -274.916 0 -100,00
2015-01-29 2015-01-28 4 BOX BOX INC
Series D2 Preferred Stock
C - Conversion -1.653.761 0 -100,00
2015-01-29 2015-01-28 4 BOX BOX INC
Existing Class A Common Stock
J - Other -2.091.457 0 -100,00
2015-01-29 2015-01-28 4 BOX BOX INC
Existing Class A Common Stock
C - Conversion 1.928.677 2.091.457 1.184,84
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
1.793.891
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3.587.767
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
1.793.891
2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock
3.587.767
2015-01-22 3 BOX BOX INC
Existing Class A Common Stock
325.560
2015-01-22 3 BOX BOX INC
Existing Class A Common Stock
325.560
2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock
J - Other -10.000 0 -100,00
2014-12-29 2014-12-26 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -1.972 0 -100,00 21,28 -41.961
2014-12-29 2014-12-26 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -296 0 -100,00 21,54 -6.377
2014-12-29 2014-12-26 4 ARDX ARDELYX, INC.
Common Stock
S - Sale -296 5.619.734 -0,01 21,54 -6.377 121.076.607
2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock
J - Other 1.972 1.972
2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock
J - Other 296 296
2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock
J - Other 296 296
2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock
J - Other -10.000 0 -100,00
2014-12-29 2014-12-23 4 ILIU INTERLEUKIN GENETICS INC
Common Stock Warrant (right to buy)
P - Purchase 19.868.965 19.868.965
2014-12-29 2014-12-23 4 ILIU INTERLEUKIN GENETICS INC
Common Stock
P - Purchase 19.868.965 35.298.087 128,78 0,10 1.992.857 3.540.398
2014-12-22 2014-12-22 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -55.994 3.569.210 -1,54 8,01 -448.512 28.589.372
2014-12-22 2014-12-19 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -27.790 3.625.204 -0,76 7,91 -219.683 28.657.600
2014-12-18 2014-12-18 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -52.998 3.652.994 -1,43 7,90 -418.742 28.862.671
2014-12-18 2014-12-17 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -63.094 3.705.992 -1,67 7,72 -487.269 28.621.006
2014-12-18 2014-12-16 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -27.233 3.769.086 -0,72 7,76 -211.238 29.235.669
2014-12-16 2014-12-12 4 ARDX ARDELYX, INC.
Common Stock
J - Other -1.000.000 5.619.734 -15,11
2014-12-15 2014-12-15 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -16.859 3.796.319 -0,44 7,82 -131.827 29.684.937
2014-12-15 2014-12-12 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -56.420 3.813.178 -1,46 7,93 -447.174 30.222.486
2014-12-15 2014-12-11 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -53.182 3.869.598 -1,36 7,92 -421.201 30.647.216
2014-12-10 2014-12-10 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -31.220 3.922.780 -0,79 7,87 -245.804 30.885.224
2014-12-10 2014-12-09 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -26.992 3.954.000 -0,68 7,79 -210.195 30.790.984
2014-12-10 2014-12-08 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -21.448 3.980.992 -0,54 7,71 -165.340 30.689.069
2014-12-10 2014-12-10 4 TRVN TREVENA INC
Common Stock
P - Purchase 1.000.000 4.811.691 26,24 4,00 4.000.000 19.246.764
2014-12-05 2014-12-05 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -18.959 4.002.440 -0,47 7,83 -148.525 31.355.115
2014-12-05 2014-12-04 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -38.061 4.021.399 -0,94 7,83 -297.903 31.475.490
2014-12-05 2014-12-03 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -46.635 4.059.460 -1,14 7,92 -369.405 32.155.795
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion -1.250.000 1.964.192 -38,89
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 69.572 69.572
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 3.920 3.920
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 2.857 2.857
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 6.777 6.777
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 13.553 20.522 194,48
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -383.750 0 -100,00
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 383.750 383.750
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -1.250.000 0 -100,00
2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock
C - Conversion 1.250.000 1.250.000
2014-12-02 2014-12-02 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -61.569 4.106.095 -1,48 7,90 -486.432 32.440.614
2014-12-02 2014-12-01 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -24.796 4.167.664 -0,59 7,89 -195.519 32.862.447
2014-12-02 2014-11-28 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -50.500 4.192.460 -1,19 7,99 -403.515 33.499.432
2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock
J - Other 2.639 2.639
2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock
J - Other 252 252
2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock
J - Other 252 252
2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock
J - Other -10.000 0 -100,00
2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock
J - Other 10.000 10.000
2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock
J - Other -1.000.000 3.994.106 -20,02
2014-11-26 2014-11-26 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -76.600 4.242.960 -1,77 8,01 -613.221 33.967.016
2014-11-26 2014-11-25 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -50.000 4.319.560 -1,14 7,90 -394.990 34.123.660
2014-11-26 2014-11-24 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -23.400 4.369.560 -0,53 7,72 -180.566 33.717.710
2014-11-21 2014-11-21 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -24.459 4.392.960 -0,55 7,66 -187.395 33.657.102
2014-11-21 2014-11-20 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -21.550 4.417.419 -0,49 7,69 -165.655 33.956.700
2014-11-21 2014-11-19 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -28.991 4.438.969 -0,65 7,69 -223.063 34.154.315
2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Series C Preferred Stock
C - Conversion -382.840 0 -100,00
2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Series B Preferred Stock
C - Conversion -655.321 0 -100,00
2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Series A Preferred Stock
C - Conversion -2.378.408 0 -100,00
2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Common Stock
P - Purchase 69.112 3.502.922 2,01 16,00 1.105.792 56.046.752
2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Common Stock
C - Conversion 3.416.569 3.433.810 19.816,54
2014-10-02 3 DERM Dermira, Inc.
Common Stock
34.482
2014-10-02 3 DERM Dermira, Inc.
Common Stock
34.482
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series C Preferred Stock
C - Conversion -58.692 0 -100,00
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series B Preferred Stock
C - Conversion -1.479.058 0 -100,00
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
C - Conversion -172.825 0 -100,00
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
P - Purchase 813.474 2.611.564 45,24 8,00 6.507.792 20.892.512
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
C - Conversion 58.692 1.798.090 3,37
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
C - Conversion 1.479.058 1.739.398 568,13
2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock
C - Conversion 260.340 260.340
2014-08-29 2014-08-29 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -11.600 4.659.333 -0,25 7,51 -87.070 34.972.953
2014-08-29 2014-08-28 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -146.800 4.670.933 -3,05 7,87 -1.154.846 36.745.296
2014-08-29 2014-08-27 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -108.300 4.817.733 -2,20 8,17 -884.811 39.360.879
2014-08-26 2014-08-25 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -7.099 0 -100,00 60,40 -428.773
2014-08-25 2014-08-22 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -27.921 7.099 -79,73 61,02 -1.703.739 433.181
2014-08-25 2014-08-22 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -24.391 35.020 -41,05 60,46 -1.474.680 2.117.309
2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -8.712 0 -100,00 59,89 -521.728
2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -100 0 -100,00 60,65 -6.065
2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -4.939 100 -98,02 59,49 -293.811 5.949
2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -343 0 -100,00 59,70 -20.478
2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -3.330 343 -90,66 60,02 -199.857 20.586
2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -400 6.969 -5,43 60,56 -24.223 422.017
2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -10.055 7.369 -57,71 59,73 -600.618 440.175
2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -9.348 59.411 -13,60 59,79 -558.917 3.552.184
2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -20.652 68.759 -23,10 59,19 -1.222.392 4.069.845
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion -1.607.096 3.214.192 -33,33
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 89.411 89.411
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 5.039 5.039
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 3.673 3.673
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 8.712 8.712
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 17.424 17.424
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -493.378 0 -100,00
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 493.378 493.378
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -1.607.096 0 -100,00
2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock
C - Conversion 1.607.096 1.607.096
2014-08-18 2014-08-15 4 EPZM Epizyme, Inc.
Common Stock
S - Sale -384 0 -100,00 36,94 -14.185
2014-08-18 2014-08-15 4 EPZM Epizyme, Inc.
Common Stock
S - Sale -3.027 384 -88,74 36,45 -110.334 13.997
2014-08-18 2014-08-15 4 EPZM Epizyme, Inc.
Common Stock
S - Sale -325 0 -100,00 35,93 -11.676
2014-08-18 2014-08-15 4 EPZM Epizyme, Inc.
Common Stock
S - Sale -325 0 -100,00 35,67 -11.593
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other 3.411 3.411
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other 325 325
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other 325 406.825 0,08
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other -12.900 0 -100,00
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other 12.900 12.900
2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock
J - Other -1.290.000 4.743.240 -21,38
2014-08-18 2014-08-15 4 CVT CVENT INC
Common Stock
S - Sale -2.641 0 -100,00 26,19 -69.174
2014-08-18 2014-08-15 4 CVT CVENT INC
Common Stock
S - Sale -252 0 -100,00 26,22 -6.608
2014-08-18 2014-08-15 4 CVT CVENT INC
Common Stock
S - Sale -252 0 -100,00 26,26 -6.616
2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock
J - Other 2.641 2.641
2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock
J - Other 252 252
2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock
J - Other 252 252
2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock
J - Other -10.000 0 -100,00
2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock
J - Other 10.000 10.000
2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock
J - Other -1.000.000 4.994.106 -16,68
2014-08-12 2014-08-12 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -35.540 4.926.033 -0,72 6,76 -240.190 33.291.609
2014-08-12 2014-08-08 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -675.000 4.961.573 -11,98 6,62 -4.468.568 32.846.109
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Series B Convertible Preferred Stock
C - Conversion -1.558.651 0 -100,00
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Common Stock
P - Purchase 230.769 1.789.420 14,81 13,00 2.999.997 23.262.460
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Common Stock
C - Conversion 1.558.651 1.558.651
2014-08-01 2014-07-31 4 LOXO Loxo Oncology, Inc.
Director Stock Option (right to buy)
A - Award 15.625 15.625
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Series E Preferred Stock
C - Conversion -5.987.892 0 -100,00
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Series D Preferred Stock
C - Conversion -8.555.784 0 -100,00
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Series C Preferred Stock
C - Conversion -4.030.224 0 -100,00
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Series B Preferred Stock
C - Conversion -12.360.000 0 -100,00
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock
P - Purchase 383.333 3.216.810 13,53 12,00 4.599.996 38.601.720
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock
C - Conversion 542.381 2.833.477 23,67
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock
C - Conversion 801.741 2.291.096 53,83
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock
C - Conversion 365.056 1.489.355 32,47
2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock
C - Conversion 1.119.565 1.124.299 23.649,45
2014-07-16 3 ROKA Roka BioScience, Inc.
Common Stock
9.468
2014-07-16 3 ROKA Roka BioScience, Inc.
Common Stock
9.468
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
C - Conversion -72.190 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
J - Other -468 72.190 -0,64 14,00 -6.552 1.010.660
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
X - Other 72.658 72.658
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock Purchase Warrant
X - Other -72.658 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
C - Conversion -216.573 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
J - Other -1.402 216.573 -0,64 14,00 -19.628 3.032.022
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
X - Other 217.975 217.975
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock Purchase Warrant
X - Other -217.975 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock
C - Conversion -4.404.887 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series A Preferred Stock
C - Conversion -1.415.642 0 -100,00
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
P - Purchase 510.442 6.619.734 8,36 14,00 7.146.188 92.676.276
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 72.190 6.109.292 1,20
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 216.573 6.037.102 3,72
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 4.404.887 5.820.529 311,16
2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock
C - Conversion 1.415.642 1.415.642
2014-06-16 2014-06-12 4 CLVS Clovis Oncology, Inc.
Stock Option (Right to Buy)
A - Award -12.414 12.414 -50,00
2014-06-16 2014-06-12 4 FOLD AMICUS THERAPEUTICS INC
Director Stock Option (Right to Buy)
A - Award 15.000 15.000
2014-06-09 2014-06-06 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
S - Sale -1.134 0 -100,00 26,90 -30.506
2014-06-09 2014-06-06 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
S - Sale -148 0 -100,00 26,80 -3.966
2014-06-09 2014-06-06 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
S - Sale -148 0 -100,00 26,77 -3.962
2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other 1.134 1.134
2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other 148 148
2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other 148 148
2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other -5.000 0 -100,00
2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other 5.000 5.000
2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other -500.000 2.384.221 -17,34
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Warrant to Purchase Common Stock (right to buy)
C - Conversion 55.831 55.831
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Warrant to Purchase Series D Preferred Stock (right to buy)
C - Conversion -55.831 0 -100,00 15,81 -882.470
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series E Preferred Stock
C - Conversion -411.234 0 -100,00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series D Preferred Stock
C - Conversion -1.236.487 0 -100,00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series C Preferred Stock
C - Conversion -531.758 0 -100,00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series B Preferred Stock
C - Conversion -383.249 0 -100,00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series A Preferred Stock
C - Conversion -797.208 0 -100,00
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 411.234 3.943.269 11,64
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 1.236.487 3.532.035 53,86
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 531.758 2.295.548 30,15
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 383.249 1.763.790 27,76
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
C - Conversion 797.208 1.380.541 136,66
2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock
P - Purchase 583.333 583.333 12,00 6.999.996 6.999.996
2014-04-09 2014-04-09 4 OPWR OPOWER, INC.
Series C Preferred Stock
C - Conversion -1.123.596 0 -100,00
2014-04-09 2014-04-09 4 OPWR OPOWER, INC.
Series B Preferred Stock
C - Conversion -7.866.170 0 -100,00
2014-04-09 2014-04-09 4 OPWR OPOWER, INC.
Common Stock
C - Conversion 8.989.766 8.989.766
2014-04-03 2014-04-02 4 HIVE AEROHIVE NETWORKS, INC
Series E Preferred Stock
C - Conversion -1.065.143 0 -100,00
2014-04-03 2014-04-02 4 HIVE AEROHIVE NETWORKS, INC
Series D Preferred Stock
C - Conversion -3.588.446 0 -100,00
2014-04-03 2014-04-02 4 HIVE AEROHIVE NETWORKS, INC
Common Stock
C - Conversion 4.653.589 4.673.589 23.267,94
2014-03-27 3 HIVE AEROHIVE NETWORKS, INC
Common Stock
40.000
2014-03-27 3 HIVE AEROHIVE NETWORKS, INC
Common Stock
40.000
2014-03-13 2014-03-05 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -14.500 0 -100,00 95,34 -1.382.475
2014-03-13 2014-03-05 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -20.500 14.500 -58,57 94,28 -1.932.767 1.367.079
2014-03-11 2014-03-07 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -1.491 35.000 -4,09 93,07 -138.765 3.257.387
2014-03-11 2014-03-07 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -11.433 36.491 -23,86 91,05 -1.041.007 3.322.608
2014-03-11 2014-03-07 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -10.700 47.924 -18,25 90,62 -969.620 4.342.811
2014-03-07 2014-03-06 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -7.702 58.624 -11,61 96,13 -740.368 5.635.332
2014-03-07 2014-03-06 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -22.146 66.326 -25,03 95,42 -2.113.081 6.328.555
2014-03-07 2014-03-06 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -20.152 88.472 -18,55 94,32 -1.900.672 8.344.396
2014-03-07 2014-03-05 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -5.039 0 -100,00 95,50 -481.224
2014-03-07 2014-03-05 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -3.673 0 -100,00 95,50 -350.772
2014-03-07 2014-03-05 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -8.712 0 -100,00 95,50 -831.996
2014-03-07 2014-03-05 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -17.425 0 -100,00 95,50 -1.664.088
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion -1.607.096 4.821.288 -25,00
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 89.428 108.624 465,87
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -10.804 19.196 -36,01 97,31 -1.051.373 1.868.026
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 5.039 5.039
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 3.673 3.673
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 8.712 8.712
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 17.425 17.425
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -493.378 0 -100,00
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 493.378 493.378
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -1.607.096 0 -100,00
2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock
C - Conversion 1.607.096 1.607.096
2014-03-05 2014-03-03 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -10.000 30.000 -25,00 96,00 -960.012 2.880.036
2014-03-05 2014-03-03 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -20.000 40.000 -33,33 95,14 -1.902.702 3.805.404
2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -6.516 60.000 -9,80 97,11 -632.769 5.826.600
2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -14.874 66.516 -18,27 96,70 -1.438.316 6.432.097
2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -16.547 81.390 -16,90 95,54 -1.580.900 7.776.001
2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -80.819 97.937 -45,21 94,47 -7.634.971 9.252.108
2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -10.078 0 -100,00 95,35 -960.937
2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -7.346 0 -100,00 95,45 -701.180
2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -17.424 0 -100,00 95,27 -1.659.972
2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -34.848 0 -100,00 94,90 -3.307.009
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion -3.214.192 6.428.384 -33,33
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 178.756 178.756
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 10.078 10.078
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 7.346 7.346
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 17.424 17.424
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 34.848 34.848
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -986.757 0 -100,00
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
J - Other 986.757 986.757
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
J - Other -3.214.192 0 -100,00
2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock
C - Conversion 3.214.192 3.214.192
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series C Preferred Stock
C - Conversion -4.840.686 0 -100,00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Preferred Stock
C - Conversion -1.462.857 0 -100,00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Preferred Stock
S - Sale -487.143 1.462.857 -24,98 1,13 -549.984 1.651.566
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Preferred Stock
X - Other 550.000 1.950.000 39,29 1,00 550.000 1.950.000
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Warrants
X - Other -550.000 0 -100,00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B Preferred Stock
C - Conversion -8.400.000 0 -100,00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series A Preferred Stock
C - Conversion -6.000.000 0 -100,00
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Common Stock
P - Purchase 472.410 3.811.691 14,15 7,00 3.306.870 26.681.837
2014-02-07 2014-02-05 4 TRVN TREVENA INC
Common Stock
C - Conversion 3.339.281 3.339.281
2014-01-29 2014-01-29 4 CRCM Care.com Inc
Series E Convertible Preferred Stock
C - Conversion -612.089 0 -100,00
2014-01-29 2014-01-29 4 CRCM Care.com Inc
Series D Convertible Preferred Stock
C - Conversion -401.837 0 -100,00
2014-01-29 2014-01-29 4 CRCM Care.com Inc
Series C Convertible Preferred Stock
C - Conversion -2.242.087 0 -100,00
2014-01-29 2014-01-29 4 CRCM Care.com Inc
Common Stock
C - Conversion 612.089 3.256.013 23,15
2014-01-29 2014-01-29 4 CRCM Care.com Inc
Common Stock
C - Conversion 401.837 2.643.924 17,92
2014-01-29 2014-01-29 4 CRCM Care.com Inc
Common Stock
C - Conversion 2.242.087 2.242.087
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock Warrant (right to buy)
X - Other -56.983 0 -100,00
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock Warrant (right to buy)
X - Other -160.672 0 -100,00
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock Warrant (right to buy)
X - Other -749.721 0 -100,00
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
D - Sale to Issuer -13.551 2.316.692 -0,58 10,96 -148.519 25.390.944
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
X - Other 56.983 2.330.243 2,51 10,96 624.534 25.539.463
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
D - Sale to Issuer -38.210 2.273.260 -1,65 10,96 -418.782 24.914.930
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
X - Other 160.672 2.311.470 7,47 10,96 1.760.965 25.333.711
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
D - Sale to Issuer -260.280 2.150.798 -10,80 16,00 -4.164.480 34.412.768
2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock
X - Other 749.721 2.411.078 45,13 16,00 11.995.536 38.577.248
2014-01-23 2014-01-21 4 SUPN SUPERNUS PHARMACEUTICALS INC
Director Stock Option (Right to Buy)
A - Award 7.457 7.457
2014-01-23 2014-01-21 4 CVT CVENT INC
Common Stock
S - Sale -169.887 5.994.106 -2,76 35,50 -6.030.988 212.790.763
2014-01-21 2014-01-16 4 CVT CVENT INC
Common Stock
S - Sale -1.132.589 6.163.993 -15,52 35,50 -40.206.910 218.821.752
2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Series A-1 Preferred Stock
C - Conversion -11.824.058 0 -100,00
2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Series A-1 Preferred Stock
C - Conversion -11.250.850 0 -100,00
2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Common Stock
P - Purchase 512.500 4.093.377 14,31 8,00 4.100.000 32.747.016
2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Common Stock
C - Conversion 3.580.877 3.580.877
2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Common Stock
P - Purchase 487.500 4.481.758 12,21 8,00 3.900.000 35.854.064
2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Common Stock
C - Conversion 3.407.283 3.994.258 580,48
2014-01-13 2014-01-09 4 GLYC GLYCOMIMETICS INC
Stock Option (right to buy)
A - Award 15.401 15.401
2014-01-09 3 GLYC GLYCOMIMETICS INC
Common Stock
586.975
2013-12-12 2013-12-11 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -562 0 -100,00 6,22 -3.496
2013-12-12 2013-12-11 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -1.452 0 -100,00 6,22 -9.031
2013-12-12 2013-12-10 4 WIFI BOINGO WIRELESS INC
Common Stock
J - Other 562 562
2013-12-12 2013-12-10 4 WIFI BOINGO WIRELESS INC
Common Stock
J - Other 1.452 1.452
2013-12-12 2013-12-10 4 WIFI BOINGO WIRELESS INC
Common Stock
J - Other -10.000 0 -100,00
2013-12-12 2013-12-10 4 WIFI BOINGO WIRELESS INC
Common Stock
J - Other 10.000 10.000
2013-12-12 2013-12-10 4 WIFI BOINGO WIRELESS INC
Common Stock
J - Other -1.000.000 4.467.960 -18,29
2013-12-05 2013-12-05 4 TRGT TARGACEPT INC
Common Stock
S - Sale -1.000 0 -100,00 5,13 -5.131
2013-12-05 2013-12-03 4 TRGT TARGACEPT INC
Director Stock Option (right to buy)
M - Exercise -7.500 0 -100,00
2013-12-05 2013-12-03 4 TRGT TARGACEPT INC
Director Stock Option (right to buy)
M - Exercise -7.500 0 -100,00
2013-12-05 2013-12-03 4 TRGT TARGACEPT INC
Common Stock
S - Sale -15.000 0 -100,00 5,38 -80.754
2013-12-05 2013-12-03 4 TRGT TARGACEPT INC
Common Stock
M - Exercise 7.500 15.000 100,00 4,16 31.200 62.400
2013-12-05 2013-12-03 4 TRGT TARGACEPT INC
Common Stock
M - Exercise 7.500 7.500 2,71 20.325 20.325
2013-11-22 2013-11-21 4 TRGT TARGACEPT INC
Common Stock
S - Sale -5.333 1.000 -84,21 5,16 -27.533 5.163
2013-11-20 2013-11-20 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion -1.152.625 9.642.576 -10,68
2013-11-20 2013-11-20 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -1.152.625 0 -100,00 62,72 -72.298.403
2013-11-20 2013-11-20 4 DATA Tableau Software Inc
Class A Common Stock
C - Conversion 1.152.625 1.152.625
2013-11-18 2013-11-15 4 EPZM Epizyme, Inc.
Common Stock
P - Purchase 25.800 406.500 6,78 19,31 498.185 7.849.312
2013-11-18 2013-11-15 4 EPZM Epizyme, Inc.
Common Stock
P - Purchase 23.700 380.700 6,64 20,31 481.269 7.730.761
2013-11-18 2013-11-14 4 EPZM Epizyme, Inc.
Common Stock
P - Purchase 163.620 357.000 84,61 19,04 3.115.538 6.797.744
2013-11-18 2013-11-14 4 EPZM Epizyme, Inc.
Common Stock
P - Purchase 152.459 193.380 372,57 19,99 3.047.335 3.865.260
2013-11-18 2013-11-14 4 EPZM Epizyme, Inc.
Common Stock
P - Purchase 40.921 40.921 20,91 855.654 855.654
2013-11-14 2013-11-13 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion -6.756.077 10.795.201 -38,49
2013-11-14 2013-11-13 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -6.756.077 0 -100,00 62,72 -423.774.930
2013-11-14 2013-11-13 4 DATA Tableau Software Inc
Class A Common Stock
C - Conversion 6.756.077 6.756.077
2013-11-13 2013-11-12 4 ECOM CHANNELADVISOR CORP
Common Stock
S - Sale -201.012 1.661.357 -10,79 32,37 -6.506.758 53.778.126
2013-11-13 2013-11-12 4 ECOM CHANNELADVISOR CORP
Common Stock
S - Sale -903.229 1.862.369 -32,66 32,37 -29.237.523 60.284.885
2013-11-06 2013-11-05 4 ADNC AUDIENCE INC
Common Stock
S - Sale -2.573 0 -100,00 9,83 -25.288
2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock
J - Other 508 508
2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock
J - Other 254 254
2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock
J - Other 107 107
2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock
J - Other 147 147
2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock
J - Other 2.573 2.573
2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock
J - Other -14.390 0 -100,00
2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock
J - Other 14.390 14.390
2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock
J - Other -1.439.003 1.439.002 -50,00
2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock
J - Other 162 952 20,51
2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock
J - Other 790 790
2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock
J - Other 3.994 3.994
2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock
J - Other 167 167
2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock
J - Other 229 229
2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock
J - Other 395 395
2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock
J - Other -22.394 0 -100,00
2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock
J - Other 22.394 22.394
2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock
J - Other -2.239.385 2.239.385 -50,00
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 41.260 41.260
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 5.918 5.918
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 5.918 5.918
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other -200.000 0 -100,00
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 200.000 200.000
2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other -20.000.000 54.184.956 -26,96
2013-09-13 2013-06-04 4/A CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.483 0 -100,00 70,80 -175.796
2013-09-13 2013-06-03 4/A CLVS Clovis Oncology, Inc.
Common Stock
J - Other 287 287
2013-09-13 2013-06-03 4/A CLVS Clovis Oncology, Inc.
Common Stock
J - Other 2.483 2.483
2013-09-13 2013-06-03 4/A CLVS Clovis Oncology, Inc.
Common Stock
J - Other 287 287
2013-09-13 2013-06-03 4/A CLVS Clovis Oncology, Inc.
Common Stock
J - Other -11.399 0 -100,00
2013-09-13 2013-06-03 4/A CLVS Clovis Oncology, Inc.
Common Stock
J - Other 11.399 11.399
2013-09-13 2013-06-03 4/A CLVS Clovis Oncology, Inc.
Common Stock
J - Other -1.139.890 2.279.781 -33,33
2013-08-23 2013-08-22 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -543 0 -100,00 7,23 -3.926
2013-08-23 2013-08-22 4 WIFI BOINGO WIRELESS INC
Common Stock
S - Sale -1.414 0 -100,00 7,16 -10.121
2013-08-23 2013-08-21 4 WIFI BOINGO WIRELESS INC
Common Stock
J - Other 543 543
2013-08-23 2013-08-21 4 WIFI BOINGO WIRELESS INC
Common Stock
J - Other 1.414 1.414
2013-08-23 2013-08-21 4 WIFI BOINGO WIRELESS INC
Common Stock
J - Other -9.650 0 -100,00
2013-08-23 2013-08-21 4 WIFI BOINGO WIRELESS INC
Common Stock
J - Other 9.650 9.650
2013-08-23 2013-08-21 4 WIFI BOINGO WIRELESS INC
Common Stock
J - Other -965.000 5.467.960 -15,00
2013-08-16 2013-08-15 4 GRPN Groupon, Inc.
Class A Common Stock
S - Sale -27.595 0 -100,00 9,77 -269.628
2013-08-16 2013-08-15 4 GRPN Groupon, Inc.
Class A Common Stock
S - Sale -3.846 0 -100,00 9,77 -37.575
2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 27.595 27.595
2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 3.846 3.846
2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other -130.000 0 -100,00
2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other 130.000 130.000
2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock
J - Other -13.000.000 74.184.956 -14,91
2013-08-14 2013-08-14 4 CVT CVENT INC
Series A Preferred Stock
C - Conversion -7.296.582 0 -100,00
2013-08-14 2013-08-14 4 CVT CVENT INC
Common Stock
C - Conversion 7.296.582 7.296.582
2013-07-18 2013-07-18 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -5.833.213 0 -100,00
2013-06-17 2013-06-13 4 CLVS Clovis Oncology, Inc.
Stock Option (Right to Buy)
A - Award -12.414 12.414 -50,00
2013-06-17 2013-06-13 4 FOLD AMICUS THERAPEUTICS INC
Director Stock Option (Right to Buy)
A - Award 15.000 15.000
2013-06-11 2013-06-10 4 TSRO TESARO, Inc.
Common Stock
S - Sale -415 0 -100,00 40,49 -16.803
2013-06-07 2013-06-05 4 EPZM Epizyme, Inc.
Series B Preferred Stock
C - Conversion -16.899.721 0 -100,00
2013-06-07 2013-06-05 4 EPZM Epizyme, Inc.
Common Stock
P - Purchase 400.000 6.033.240 7,10 15,00 6.000.000 90.498.600
2013-06-07 2013-06-05 4 EPZM Epizyme, Inc.
Common Stock
C - Conversion 5.633.240 5.633.240
2013-06-05 2013-06-05 4 TSRO TESARO, Inc.
Common Stock
S - Sale -3.583 0 -100,00 39,00 -139.726
2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock
J - Other 3.583 3.583
2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock
J - Other 415 415
2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock
J - Other -16.450 0 -100,00
2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock
J - Other 16.450 16.450
2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock
J - Other -1.645.000 9.854.255 -14,31
2013-06-05 2013-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2.483 0 -100,00 70,80 -175.796
2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other 2.483 2.483
2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other 287 287
2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other -11.399 0 -100,00
2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other 11.399 11.399
2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
J - Other -1.139.890 2.279.781 -33,33
2013-06-04 2013-06-03 4 TRGT TARGACEPT INC
Stock Option (Right to Buy)
X - Other -1.000 0 -100,00
2013-06-04 2013-06-03 4 TRGT TARGACEPT INC
Common Stock
X - Other 1.000 6.333 18,75 0,08 75 475
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Series C Preferred Stock
C - Conversion -44.249.588 0 -100,00
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Series C Preferred Stock
S - Sale -95.980 44.249.588 -0,22 0,88 -83.982 38.718.390
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Series C Preferred Stock
X - Other 122.602 44.345.568 0,28 0,68 83.982 30.376.714
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Warrant to Purchase Series C Preferred Stock (right to buy)
X - Other -122.602 0 -100,00
2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Common Stock
C - Conversion 2.765.599 2.765.599
2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion -2.000.000 17.551.278 -10,23
2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion 6.541.485 19.551.278 50,28
2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Series B Common Stock
C - Conversion -6.541.485 0 -100,00
2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class B Common Stock
C - Conversion 10.602.127 13.009.793 440,35
2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Series A Preferred Stock
C - Conversion -10.602.127 0 -100,00
2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class A Common Stock
S - Sale -2.000.000 0 -100,00 28,83 -57.660.000
2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class A Common Stock
C - Conversion 2.000.000 2.000.000
2013-05-23 3 ILIU INTERLEUKIN GENETICS INC
Common Stock
15.429.122
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Series B Preferred Stock
C - Conversion -6.165.747 0 -100,00
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Secured Convertible Promissory Note
C - Conversion -633.219 0 -100,00
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Warrant (right to buy)
C - Conversion -156.250 0 -100,00
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock
P - Purchase 625.000 5.833.213 12,00 8,00 5.000.000 46.665.704
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock
C - Conversion 4.418.940 5.208.213 559,87
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock
C - Conversion 633.219 789.273 405,77 8,00 5.065.752 6.314.184
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock
S - Sale -196 156.054 -0,13 8,00 -1.568 1.248.432
2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock
C - Conversion 156.250 156.250 0,01 1.562 1.562
2013-04-11 2013-04-11 4 OMTH Omthera Pharmaceuticals, Inc.
Secured Convertible Promissory Note
A - Award 633.219 633.219
2013-04-11 2013-04-11 4 OMTH Omthera Pharmaceuticals, Inc.
Warrant (right to buy)
A - Award 156.250 156.250
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class B Common Stock
C - Conversion -2.321.212 4.642.425 -33,33
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 5.344 10.396 105,78
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 687 1.273 117,24
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 687 1.273 117,24
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other -23.212 0 -100,00
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 23.212 23.212
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
J - Other -2.321.212 0 -100,00
2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock
C - Conversion 2.321.212 2.321.212
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class B Common Stock
C - Conversion -2.321.212 4.642.425 -33,33
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 5.052 5.052
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 586 586
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 586 586
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock
J - Other -23.212 0 -100,00
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock
J - Other 23.212 23.212
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock
J - Other -2.321.212 0 -100,00
2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock
C - Conversion 2.321.312 2.321.212 -2.321.312,00
2013-03-08 2013-03-08 4 ADNC AUDIENCE INC
Common Stock
S - Sale -510 0 -100,00 12,97 -6.615
2013-03-08 2013-03-08 4 ADNC AUDIENCE INC
Common Stock
S - Sale -148 0 -100,00 12,97 -1.920
2013-03-08 2013-03-07 4 ADNC AUDIENCE INC
Common Stock
S - Sale -2.792 0 -100,00 12,96 -36.187
2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series F Convertible Preferred Stock
C - Conversion -189.966 0 -100,00
2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series E Convertible Preferred Stock
C - Conversion -681.458 0 -100,00
2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series D Convertible Preferred Stock
C - Conversion -848.420 0 -100,00
2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series C-1 Convertible Preferred Stock
C - Conversion -502.386 0 -100,00
2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series C Convertible Preferred Stock
C - Conversion -2.256.540 0 -100,00
2013-02-25 2013-02-21 4 XOOM XOOM Corp
Common Stock
C - Conversion 4.478.770 4.478.770
2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock
J - Other 510 510
2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock
J - Other 148 148
2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock
J - Other 2.792 2.792
2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock
J - Other -14.000 0 -100,00
2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock
J - Other 14.000 14.000
2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock
J - Other -1.400.000 2.878.005 -32,73
2013-02-07 2013-02-05 4 SUPN SUPERNUS PHARMACEUTICALS INC
Director Stock Option (Right to Buy)
A - Award 8.722 8.722
2012-10-30 2012-10-29 4 MM Millennial Media Inc.
Common Stock
S - Sale -1.597.787 8.196.614 -16,31 13,44 -21.478.252 110.182.984
2012-10-18 2012-10-17 4 WDAY Workday, Inc.
Class B Common Stock
C - Conversion 6.963.636 13.927.273 100,00
2012-10-18 2012-10-17 4 WDAY Workday, Inc.
Series E Convertible Preferred Stock
C - Conversion -6.963.636 0 -100,00
2012-10-18 2012-10-17 4 WDAY Workday, Inc.
Class B Common Stock
C - Conversion 6.963.637 6.963.637
2012-10-18 2012-10-17 4 WDAY Workday, Inc.
Series E Convertible Preferred Stock
C - Conversion -6.963.637 0 -100,00
2012-09-20 2012-08-23 4 FIO FUSION-IO, INC.
Common Stock
G - Gift -2.673 1.333 -66,72
2012-09-06 2012-09-05 4 FIO FUSION-IO, INC.
Common Stock
S - Sale -64.634 0 -100,00 27,67 -1.788.494
2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock
J - Other 1.333 4.006 49,87
2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock
J - Other -45.000 0 -100,00
2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock
J - Other 45.000 45.000
2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock
J - Other -4.500.000 9.038.379 -33,24
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-1 Preferred Stock
C - Conversion -611.185 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Convertible Promissory Note
C - Conversion 0
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Convertible Promissory Note
C - Conversion 0
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Convertible Promissory Note
C - Conversion 0
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
C - Conversion -2.043 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
C - Conversion -2.043 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
J - Other -51.744 2.043 -96,20 10,00 -517.440 20.430
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
J - Other -51.744 2.043 -96,20 10,00 -517.440 20.430
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
X - Other 53.787 53.787
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
X - Other 53.787 53.787
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Preferred Stock Warrant (right to buy)
X - Other -53.787 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Preferred Stock Warrant (right to buy)
X - Other -53.787 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock Warrant (right to buy)
X - Other -125.291 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock
C - Conversion -898.808 0 -100,00
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
P - Purchase 500.000 2.884.221 20,97 10,00 5.000.000 28.842.210
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 177.481 2.384.221 8,04
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 180.459 2.206.740 8,91
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 434.096 2.026.281 27,26
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 2.043 1.592.185 0,13
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 2.043 1.592.185 0,13
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
J - Other -51.119 1.588.099 -3,12
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
X - Other 125.291 1.639.218 8,28
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 898.808 1.513.927 146,12
2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock
C - Conversion 611.185 615.119 15.535,97
2012-07-25 3 HPTX HYPERION THERAPEUTICS INC
Common Stock
3.934
2012-07-03 2012-07-03 4 TSRO TESARO, Inc.
Series B Preferred Stock
C - Conversion -5.253.859 0 -100,00
2012-07-03 2012-07-03 4 TSRO TESARO, Inc.
Series A Preferred Stock
C - Conversion -5.134.285 0 -100,00
2012-07-03 2012-07-03 4 TSRO TESARO, Inc.
Common Stock
P - Purchase 1.111.111 11.499.255 10,70 13,50 14.999.998 155.239.942
2012-07-03 2012-07-03 4 TSRO TESARO, Inc.
Common Stock
C - Conversion 10.388.144 10.388.144
2012-06-18 2012-06-14 4 CLVS Clovis Oncology, Inc.
Stock Option (Right to Buy)
A - Award -12.414 12.414 -50,00
2012-06-15 2012-06-13 4 FOLD AMICUS THERAPEUTICS INC
Director Stock Option (Right to Buy)
A - Award 15.000 15.000
2012-06-11 2012-06-07 4 TRGT TARGACEPT INC
Director Stock Option (Right to Buy)
A - Award 7.500 7.500
2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series E Preferred Stock
C - Conversion -1.349.396 0 -100,00
2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series D Preferred Stock
C - Conversion -1.111.435 0 -100,00
2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series C Preferred Stock
C - Conversion -450.952 0 -100,00
2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series B-1 Preferred Stock
C - Conversion -230.379 0 -100,00
2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series B Preferred Stock
C - Conversion -1.135.843 0 -100,00
2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Common Stock
C - Conversion 4.278.005 4.278.005
2012-05-08 2012-05-04 4 SUPN SUPERNUS PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -24.965.000 0 -100,00
2012-05-08 2012-05-04 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
P - Purchase 4.400.000 10.641.250 70,50 5,00 22.000.000 53.206.250
2012-05-08 2012-05-04 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock
C - Conversion 6.241.250 6.241.250
2012-05-01 2012-04-27 4 FIO FUSION-IO, INC.
Common Stock
J - Other 2.074 2.673 346,24
2012-05-01 2012-04-27 4 FIO FUSION-IO, INC.
Common Stock
J - Other -69.998 0 -100,00
2012-04-04 2012-04-03 4 MM Millennial Media Inc.
Series D Preferred Stock
C - Conversion -1.758.302 0 -100,00
2012-04-04 2012-04-03 4 MM Millennial Media Inc.
Series C Preferred Stock
C - Conversion -8.036.099 0 -100,00
2012-04-04 2012-04-03 4 MM Millennial Media Inc.
Common Stock
C - Conversion 9.794.401 9.794.401
2012-03-30 2012-03-28 4 INWK INNERWORKINGS INC
Common Stock
J - Other 5.000 15.000 50,00
2012-03-30 2012-03-28 4 INWK INNERWORKINGS INC
Common Stock
J - Other -500.000 4.529.190 -9,94
2012-03-28 2012-03-26 4 INWK INNERWORKINGS INC
Common Stock
J - Other 10.000 10.000
2012-03-28 2012-03-26 4 INWK INNERWORKINGS INC
Common Stock
J - Other -1.000.000 5.029.190 -16,59
2012-03-16 2012-03-14 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 69.998 16,67
2012-03-16 2012-03-14 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 13.538.379 -6,88
2012-03-13 2012-03-09 4 FIO FUSION-IO, INC.
Common Stock
J - Other 9.998 59.998 20,00
2012-03-13 2012-03-09 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 14.538.379 -6,44
2012-03-09 2012-03-07 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
P - Purchase 925.154 4.584.311 25,28 5,70 5.273.378 26.130.573
2012-03-07 2012-03-05 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 50.000 25,00
2012-03-07 2012-03-05 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 15.538.379 -6,05
2012-03-01 2012-02-29 4 ECHO Echo Global Logistics, Inc.
Common Stock
S - Sale -119 0 -100,00 18,76 -2.232
2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock
J - Other 119 119
2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock
J - Other -4.000 0 -100,00
2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock
J - Other 4.000 4.000
2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock
J - Other -400.000 2.020.219 -16,53
2012-03-01 2012-02-29 4 INWK INNERWORKINGS INC
Common Stock
S - Sale -455.360 6.029.190 -7,02 11,42 -5.199.164 68.839.483
2012-02-29 2012-02-27 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 40.000 33,33
2012-02-29 2012-02-27 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 16.538.379 -5,70
2012-02-28 2012-02-24 4 INWK INNERWORKINGS INC
Common Stock
S - Sale -334.457 6.484.550 -4,90 11,40 -3.812.810 73.923.870
2012-02-27 2012-02-24 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 30.000 50,00
2012-02-27 2012-02-24 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 17.538.379 -5,39
2012-02-27 2012-02-23 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 20.000 100,00
2012-02-27 2012-02-23 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 18.538.379 -5,12
2012-02-24 2012-02-23 4 INWK INNERWORKINGS INC
Common Stock
S - Sale -54.849 6.819.007 -0,80 11,75 -644.344 80.106.967
2012-02-24 2012-02-22 4 INWK INNERWORKINGS INC
Common Stock
S - Sale -253.211 6.873.856 -3,55 11,68 -2.957.808 80.294.887
2012-02-23 2012-02-21 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 10.000
2012-02-23 2012-02-21 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 19.538.379 -4,87
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock Warrant (Right to Buy)
U - Other -791.015 0 -100,00
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock Warrant (Right to Buy)
U - Other -263.671 0 -100,00
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Stock Option (right to buy)
D - Sale to Issuer -20.000 0 -100,00
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Stock Option (right to buy)
D - Sale to Issuer -20.000 0 -100,00
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Stock Option (right to buy)
D - Sale to Issuer -20.000 0 -100,00
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Stock Option (right to buy)
D - Sale to Issuer -20.000 0 -100,00
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Stock Option (right to buy)
D - Sale to Issuer -7.500 0 -100,00
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Stock Option (right to buy)
D - Sale to Issuer -7.500 0 -100,00
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Stock Option (right to buy)
D - Sale to Issuer -7.500 0 -100,00
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock
U - Other -746.596 0 -100,00 26,00 -19.411.496
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock
J - Other 746.596 746.596
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock
U - Other -248.864 0 -100,00 26,00 -6.470.464
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock
J - Other 248.864 248.864
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock
U - Other -78.689 0 -100,00 26,00 -2.045.914
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock
J - Other 78.689 78.689
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock
U - Other -68.492 0 -100,00 26,00 -1.780.792
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock
U - Other -6.898.294 0 -100,00 26,00 -179.355.644
2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock
U - Other -1.941.407 0 -100,00 26,00 -50.476.582
2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock
J - Other 300 599 100,33
2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock
J - Other -10.000 0 -100,00
2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 10.000
2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 20.538.379 -4,64
2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock
J - Other 299 299
2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock
J - Other -10.000 0 -100,00
2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 10.000
2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 21.538.379 -4,44
2012-02-06 2012-02-06 4 FIO FUSION-IO, INC.
Common Stock
S - Sale -23.083 64.634 -26,32 23,05 -532.063 1.489.814
2012-02-06 2012-02-06 4 FIO FUSION-IO, INC.
Common Stock
S - Sale -604 0 -100,00 22,19 -13.403
2012-02-06 2012-02-02 4 FIO FUSION-IO, INC.
Common Stock
J - Other 604 604
2012-02-06 2012-02-02 4 FIO FUSION-IO, INC.
Common Stock
J - Other -20.000 0 -100,00
2012-02-06 2012-02-02 4 FIO FUSION-IO, INC.
Common Stock
J - Other 10.000 20.000 100,00
2012-02-06 2012-02-02 4 FIO FUSION-IO, INC.
Common Stock
J - Other -1.000.000 22.538.379 -4,25
2012-02-03 2012-02-01 4 INHX INHIBITEX, INC.
Stock Option (right to buy)
A - Award 20.000 20.000
2012-01-20 2012-01-19 4 INHX INHIBITEX, INC.
Stock Option (right to buy)
M - Exercise -7.500 0 -100,00
2012-01-20 2012-01-19 4 INHX INHIBITEX, INC.
Common Stock
M - Exercise 7.500 68.492 12,30 8,79 65.925 602.045
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)